Company: INV
Filing Date: 2025-04-23
Form Type: 424B3
Source: 0001628280-25-019356
Chunk: 231

Company: Innventure, Inc.
Filing Date: 2025-04-23
Form: 424B3
Chunk 231
---
 (loss). As of December 31, 2024, the Company had $23,241 in stock-based compensation expense remaining to be recognized over approximately 1.65 years.

Stock Options

The stock options were granted with an exercise price of $12.20, which aligns with the Company’s closing share price on December 9, 2024. Using the Black-Scholes option pricing model, the estimated grant date fair value of stock options was $6,468 based on an expected volatility of 56%, an expected option term of approximately 5.28 - 5.62 years, and risk-free rate of return of 4.0 - 4.1%. The stock options have a maximum contractual life, and a weighted average remaining contractual term, of 10 years from the grant date.

Stock options activity for the Successor period from October 2, 2024 through December 31, 2024 is as follows:

|                                  |     | Number of Shares |     |         |     | Weighted Average Exercise Price |       |     | Weighted Average Grant Date Fair Value (per share) |      |
|:---------------------------------|:----|:-----------------|:----|--------:|:----|:--------------------------------|------:|:----|:---------------------------------------------------|-----:|
| Granted on December 9, 2024      |     |                  |     | 975,409 |     | $                               | 12.20 |     | $                                                  | 6.63 |
| Vested                           |     |                  |     |  61,560 |     |                                 | 12.20 |     |                                                    | 6.63 |
| Exercised                        |     |                  |     |       — |     |                                 |     — |     |                                                    |    — |
| Forfeited                        |     |                  |     |       — |     |                                 |     — |     |                                                    |    — |
| Outstanding at December 31, 2024 |     |                  |     | 913,849 |     | $                               | 12.20 |     | $                                                  | 6.63 |
| Exercisable at December 31, 2024 |     |                  |     |       — |     |                                 |     — |     |                                                    |    — |

During the Successor period from October 2, 2024 through December 31, 2024, the Company recognized compensation costs